Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.

Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB.

J Clin Endocrinol Metab. 2010 Mar;95(3):1131-6. doi: 10.1210/jc.2009-1389. Epub 2010 Jan 8.

2.

Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.

de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2009 Nov;94(11):4205-15. doi: 10.1210/jc.2009-0454. Epub 2009 Oct 16.

PMID:
19837938
4.
5.
6.

Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.

Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB.

J Pediatr. 2004 Dec;145(6):744-9.

PMID:
15580194
7.

Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.

Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2008 Sep;69(3):443-51. doi: 10.1111/j.1365-2265.2008.03228.x. Epub 2008 Mar 18.

PMID:
18363884
8.

Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome.

Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, Trivin C, Laborde K, Souberbielle JC, Polak M.

Horm Res Paediatr. 2011 Feb;75(2):123-30. doi: 10.1159/000319709. Epub 2010 Sep 15.

PMID:
20847547
9.

Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.

Whitman B, Carrel A, Bekx T, Weber C, Allen D, Myers S.

J Pediatr Endocrinol Metab. 2004 Apr;17(4):591-600.

PMID:
15198290
10.

Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome.

Wolfgram PM, Carrel AL, Allen DB.

Curr Opin Pediatr. 2013 Aug;25(4):509-14. doi: 10.1097/MOP.0b013e328362c7a2. Review.

11.

Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.

Carrel AL, Myers SE, Whitman BY, Allen DB.

J Clin Endocrinol Metab. 2002 Apr;87(4):1581-5.

PMID:
11932286
12.

Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.

Mogul HR, Lee PD, Whitman BY, Zipf WB, Frey M, Myers S, Cahan M, Pinyerd B, Southren AL.

J Clin Endocrinol Metab. 2008 Apr;93(4):1238-45. doi: 10.1210/jc.2007-2212. Epub 2008 Jan 22.

PMID:
18211968
13.

Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.

Höybye C, Hilding A, Jacobsson H, Thorén M.

Clin Endocrinol (Oxf). 2003 May;58(5):653-61.

PMID:
12699450
14.

Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.

Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB.

Am J Med Genet A. 2007 Mar 1;143A(5):443-8.

PMID:
17103437
15.
16.

Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.

Festen DA, van Toorenenbergen A, Duivenvoorden HJ, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2007 Apr;92(4):1549-54. Epub 2007 Jan 30.

PMID:
17264186
17.

Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.

Lindgren AC, Hagenäs L, Müller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzén EM.

Acta Paediatr. 1998 Jan;87(1):28-31.

PMID:
9510443
19.

Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment.

de Lind van Wijngaarden RF, Cianflone K, Gao Y, Leunissen RW, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2010 Apr;95(4):1758-66. doi: 10.1210/jc.2009-0656. Epub 2010 Feb 19.

PMID:
20173020
20.

Supplemental Content

Support Center